Cognito Therapeutics, Inc.

🧠 This Brain Awareness Week, we’re focusing on what matters most — bringing hope to patients and families living with Alzheimer’s and other neurodegenerative diseases. At Cognito Therapeutics, Inc., we’re developing #Spectris™ — a first-of-its-kind non-invasive disease-modifying therapy that uses gamma wave stimulation. We're evaluating Spectris™ through our pivotal HOPE study — a clinical trial designed to evaluate whether this non-invasive approach can slow disease progression for patients with Alzheimer's disease. ✅ In earlier clinical studies, Spectris™ led to significant cerebrospinal fluid (CSF) biomarker changes in pathways essential to brain health — including myelination, synaptic function, lipid metabolism, and neuroimmune regulation. 🎥 Want to learn more? Check out this powerful conversation between our CEO Christian Howell and Dr. David Perlmutter on brain health: 👉 https://lnkd.in/eWh943qN #BrainAwarenessWeek #BrainHealth #AlzheimersAwareness #HOPEStudy #Innovation #WearableTech #Neurotechnology #PatientCentered

Thanks Medical Product Outsourcing for highlighting our recent executive appointments. Steve Worthy joins the company as chief business and financial officer, Dr. Robbert Zusterzeel, M.D., Ph.D., M.P.H. as chief clinical and regulatory officer, Deanna Angello as chief commercial officer, and Pritesh Shah, PharmD, as chief strategy officer. Read the article: https://lnkd.in/eUbEcT4v

Our CEO, Christian Howell spoke today at the Investival Showcase in Miami, sharing the groundbreaking work we’re doing at Cognito to transform #Alzheimer’s and neurodegenerative disease treatment. He will also be at LSI USA 25 next week in Dana Point. More info here: https://lnkd.in/dw_teTUK More info about how to join our study: https://lnkd.in/eyvfmbWK

🌍💜 Celebrating Women in Science, Healthcare, and Innovation 💜🌍 This International Women’s Day, Cognito celebrates the brilliant women driving breakthroughs in neuroscience to transform the lives of patients affected by neurodegenerative diseases. #IWD2025 #WomenInSTEM #Neuroscience #CognitoTherapeutics

🧠 New research from our scientific co-founder, Dr. Li-Huei Tsai at The Picower Institute for Learning and Memory, reinforces the power of gamma stimulation for #brainhealth. A growing body of evidence shows that sensory stimulation using light and sound at 40Hz can enhance neural function and resilience. In Dr. Tsai’s latest review paper, findings highlight how this non-invasive approach can: 🔹 Reduce neuroinflammation 🔹 Improve blood flow 🔹 Strengthen neural connectivity This research is paving the way for a new era in neurodegenerative disease treatment—one that moves beyond traditional drug-based approaches. Read more: https://lnkd.in/eKqCf3gf #Neuroscience #BrainHealth #Alzheimers #Innovation

Citeline’s SCRIP Asks column spoke with our CEO Christian Howell for his predictions on what’s next for Alzheimer’s Disease development in 2025: “I anticipate a significant focus on novel therapies that go beyond antibody-based approaches. As current antibody therapies have shown limitations, particularly with brain inflammation, the focus will shift towards innovative solutions that offer both efficacy and safety,” said Christian Howell, CEO of Cognito Therapeutics. Read the article: https://lnkd.in/dSyX8Mmu

Our CEO Christian Howell will be presenting at the Investival Showcase in Miami, March 10-11. The presentation will be on Monday, March 10 at 10:30 am ET at the Miami Beach Convention Center. For more information, visit: https://lnkd.in/eUnJhpfJ See you there!

Alzheimer’s research is evolving—and the latest breakthroughs are nothing short of fascinating. On a recent episode of The Empowering Neurologist, I’m joined by Christian Howell, CEO of Cognito Therapeutics, Inc., to discuss a revolutionary approach to treating Alzheimer’s and other neurodegenerative conditions. In the episode, we cover: ➡ How the brain’s electrical rhythms impact memory, learning, and attention ➡ The role of gamma oscillations in clearing harmful proteins linked to Alzheimer’s ➡ How non-invasive light and sound therapy could transform brain health This is a hopeful conversation for anyone impacted by cognitive decline or interested in the future of neuroscience. Tune in here: https://lnkd.in/e3MnQbbj #BrainHealth #ProfessionalPerformance #Neurology 

Thanks Being Patient for featuring Spectris in your recent article on non-invasive treatments in development for Alzheimer’s disease. 🧠 Emerging treatments are coming online for #Alzheimers, developed with the goal of clearing harmful plaques and improving #brain function without the use of drugs. 🔗 Here's more: https://buff.ly/3ECov3d

Cognito Therapeutics at the 6th Bioelectronic Medicine (BEM) Summit: Shaping the Future of #Neurotechnology We’re proud to sponsor The Sixth BEM Summit: Neurotechnologies for Individuals and Communities, a global forum highlighting bioelectronic medicine as a transformative platform for #healthcare, #technology, and #science. 📢 Keynote Address: Dr. Ralph Kern, Chief Medical Officer, Cognito Therapeutics, Inc. 📅 March 5, 2025 | 🕣 8:45 - 9:45 AM ET Our CEO, Christian Howell, will also be in attendance as we discuss the future of non-invasive #neurotechnology and their impact on brain health. Join us as we explore how we're driving innovation in neurodegenerative disease treatment. 🔗 https://lnkd.in/eXEcF_RJ #BioelectronicMedicine #Neurotech #BrainHealth #Innovation #CognitoTherapeutics